Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$363M |
| 2 |
Nike
NKE
|
+$289M |
| 3 |
Home Depot
HD
|
+$271M |
| 4 |
Mastercard
MA
|
+$180M |
| 5 |
Amazon
AMZN
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$226M |
| 2 |
Coca-Cola
KO
|
+$225M |
| 3 |
Meta Platforms (Facebook)
META
|
+$205M |
| 4 |
Johnson & Johnson
JNJ
|
+$199M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.79% |
| 2 | Healthcare | 13.06% |
| 3 | Financials | 11.84% |
| 4 | Consumer Discretionary | 9.23% |
| 5 | Industrials | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEAC
2101
DELISTED
Seachange International Inc
SEAC
| $2.38M | ﹤0.01% |
37,286
+3,211
| +9% | +$237K |
|
|
ALSK
2102
DELISTED
Alaska Communications Systems
ALSK
| $2.37M | ﹤0.01% |
1,394,255
+42,979
| +3% | +$76.9K |
|
2103
TechTarget
TTGT
$278M
| $2.37M | ﹤0.01% |
292,100
+44,100
| +18% | +$346K |
|
2104
Global Indemnity Group
GBLI
$395M
| $2.36M | ﹤0.01% |
85,864
+707
| +0.8% | +$21.4K |
|
|
WMGI
2105
DELISTED
Wright Medical Group Inc
WMGI
| $2.36M | ﹤0.01% |
136,111
-196,367
| -59% | -$3.6M |
|
|
DGAS
2106
DELISTED
Delta Natural Gas Co Inc
DGAS
| $2.36M | ﹤0.01% |
87,700
+11,414
| +15% | +$283K |
|
2107
Watts Water Technologies
WTS
$12.8B
| $2.36M | ﹤0.01% |
40,500
+3,800
| +10% | +$215K |
|
|
NADL
2108
DELISTED
North Atlantic Drilling Ltd
NADL
| $2.35M | ﹤0.01% |
349,240
+134,500
| +63% | +$537K |
|
2109
Delek Logistics
DKL
$2.87B
| $2.35M | ﹤0.01% |
+88,001
| New | +$2.51M |
|
2110
Standard BioTools
LAB
$280M
| $2.35M | ﹤0.01% |
260,100
+152,100
| +141% | +$1.43M |
|
2111
CONMED
CNMD
$1.51B
| $2.34M | ﹤0.01% |
49,081
-54,700
| -53% | -$2.32M |
|
|
CRZO
2112
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $2.34M | ﹤0.01% |
65,252
-555,590
| -89% | -$19.9M |
|
2113
Constellium
CSTM
$4.01B
| $2.34M | ﹤0.01% |
498,200
-285,900
| -36% | -$1.47M |
|
|
PRCP
2114
DELISTED
Perceptron Inc
PRCP
| $2.34M | ﹤0.01% |
499,200
-8,894
| -2% | -$41.5K |
|
2115
PennyMac Financial
PFSI
$4.05B
| $2.33M | ﹤0.01% |
186,500
-26,500
| -12% | -$344K |
|
|
GSB
2116
DELISTED
GlobalSCAPE, Inc.
GSB
| $2.32M | ﹤0.01% |
629,809
-1,691
| -0.3% | -$6.19K |
|
|
ADVM
2117
DELISTED
Adverum Biotechnologies
ADVM
| $2.32M | ﹤0.01% |
73,514
+45,644
| +164% | +$2.06M |
|
2118
FTAI Aviation
FTAI
$22.3B
| $2.31M | ﹤0.01% |
294,858
+141,574
| +92% | +$1.21M |
|
|
AVEO
2119
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $2.31M | ﹤0.01% |
240,540
+31,050
| +15% | +$299K |
|
|
REXI
2120
DELISTED
RESOURCE AMERICA INC CL-A
REXI
| $2.31M | ﹤0.01% |
237,900
+126,900
| +114% | +$976K |
|
2121
Deluxe
DLX
$1.1B
| $2.31M | ﹤0.01% |
34,800
-124,100
| -78% | -$7.88M |
|
|
TREC
2122
DELISTED
Trecora Resources
TREC
| $2.3M | ﹤0.01% |
220,700
+48,100
| +28% | +$513K |
|
|
WSTC
2123
DELISTED
West Corporation
WSTC
| $2.29M | ﹤0.01% |
116,600
+79,800
| +217% | +$1.71M |
|
|
IMN
2124
DELISTED
Imation
IMN
| $2.29M | ﹤0.01% |
1,827,945
+164,644
| +10% | +$260K |
|
|
LIOX
2125
DELISTED
Lionbridge Technologies
LIOX
| $2.28M | ﹤0.01% |
578,200
-5,400
| -0.9% | -$24.3K |
|
Similar funds
Jim Simons's Q2 2016 Portfolio in Review
As of Q2 2016, Jim Simons held 3,774 positions worth $52.5B, down 0.13% from $52.6B the previous quarter. Its ten largest holdings account for 8% of the portfolio.
Jim Simons withdrew a net $1.64B in Q2 2016, closing 474 positions and reducing 1,158 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Jim Simons opened a new position in Nike worth $280M.
- Jim Simons's largest Q2 2016 buy was Nike: 5,066,500 shares worth $280M.
- Jim Simons added most to CVS Health in Q2 2016, an estimated $363M increase.
- Jim Simons's biggest Q2 2016 reduction was PepsiCo, cutting an estimated $226M.
- Jim Simons fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $185M.
- Jim Simons's ten largest holdings make up 8% of its $52.5B portfolio in Q2 2016.
- Jim Simons opened 423 new positions and closed 474 in Q2 2016.
- Jim Simons's portfolio value fell 0.13% quarter-over-quarter to $52.5B.
Based on Renaissance Technologies's 13F filing for Q2 2016, filed 12 Aug 2016.